MUMBAI, India, Aug. 17 -- Intellectual Property India has published a patent application (202617079136 A) filed by Genome Therapeutics Ltd on June 26, 2026, for Tetracyclic Compounds For Use In Antibody-Drug Conjugates For The Treatment Of Cancer.
Inventors include Balasubramanian, Shankar; and Meo, Paul.
The application for the patent was published on August 14, 2026, under issue no. 33/2026.
Abstract: The present invention provides compounds of Formula (I) and pharmaceutically acceptable salts and solvates thereof. The present invention also relates to antibody- drug conjugates (ADCs) comprising the compounds, to processes for the preparation of the compounds and ADCs, as well as to ADCs and pharmaceutical compositions comprising them for use in the treatment of cancer.
Disclaimer: Curated by HT Syndication.
